|
| Press Releases |
|
 |
|
| Monday, April 22, 2024 |
|
|
NEC Strengthens Commitment to Space Industry with Investment in Seraphim Space Venture Fund II |
| NEC Corporation (NEC; TSE: 6701) today announced a strategic investment in "Seraphim Space Venture Fund II," a pioneering venture capital fund specializing in the space industry and operated by Seraphim Space, the most prolific investor globally in this domain. more info >> |
|
| Thursday, April 11, 2024 |
|
|
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission |
| NTT DOCOMO, INC., NTT Corporation, NEC Corporation and Fujitsu Limited jointly announced today the development of a top-level (1) wireless device capable of ultra-high-speed 100 Gbps transmissions in the 100 GHz and 300 GHz sub-terahertz bands. more info >> |
|
| Wednesday, April 10, 2024 |
|
|
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024 |
| Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT, network and AI technologies, announced that new data will be presented on TG4050, an individualized neoantigen cancer vaccine, at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA. more info >> |
|
| Monday, April 8, 2024 |
|
|
NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines |
| NEC Corporation (TSE: 6701) has released a white paper, "Towards the realization of AI drug development: Comprehensive process workflow for the commercial use of personalized cancer vaccines". more info >> |
|
| Monday, March 25, 2024 |
|
|
NEC develops marketing strategy planning & effectiveness simulation technology using generative AI |
| NEC Corporation (TSE: 6701) has developed a marketing strategy planning & effectiveness simulation technology that utilizes generative AI to identify latent needs of customers and generate optimal measures. more info >> |
|
| Friday, March 22, 2024 |
|
|
NEC and NTT successfully conduct first-of-its-kind long-distance transmission experiment over 7,000km using 12-core optical fiber |
| NEC Corporation (TSE: 6701) and NTT Corporation (NTT) today announced that they have successfully conducted a first-of-its-kind transoceanic-class 7,280km transmission experiment using a coupled 12-core multicore fiber(1), which consists of 12 optical signal transmission paths in a standard outer diameter optical fiber (0.125 mm). more info >> |
|
| Thursday, March 21, 2024 |
|
|
NEC and Tokyo Medical and Dental University use AI to assist self-care for chronic lower back pain |
| NEC Corporation (TSE: 6701) and Tokyo Medical and Dental University (TMDU) have developed a technology to support self-care for chronic non-specific lower back pain (CLBP) by using artificial intelligence (AI) to analyze image and interview data taken with smart devices. more info >> |
|
| Wednesday, March 20, 2024 |
|
|
NEC and Skyloom to Pioneer 100 Gbps Space Optical Communications, Transforming Global Internet Connectivity |
| NEC Corporation (TSE: 6701) and Skyloom Global Corporation have joined forces to revolutionize space communications with the development of cutting-edge optical communication equipment for multi-orbit satellite networks. more info >> |
|
| Thursday, March 7, 2024 |
|
|
NEC named to list of Top 100 Global Innovators by Clarivate for 13th consecutive year |
| NEC Corporation has been named to the list of Top 100 Global Innovators 2024 by Clarivate Plc., which selects companies and organizations that "sit at the very top of the global innovation ecosystem, with the most consistent above-the-bar innovation performance." more info >> |
|
| Tuesday, March 5, 2024 |
|
|
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050 |
| Transgene, NEC Corporation today announced the expansion of their collaboration for the randomized Phase I/II trial of TG4050, an individualized therapeutic vaccine for patients with head and neck cancers. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
TCG.Zone Announces Strategic Pivot to High-Value Collectible Assets 
Feb 1, 2026 17:00 HKT/SGT
|
|
|
Five Global Megatrends Highlighted at Open Dialogue Expert Forum at the Russia National Centre
Jan 31, 2026 21:00 HKT/SGT
|
|
|
REMSleep Receives Medicare PDAC Coding Approval for Complete DeltaWave Product Portfolio
Jan 31, 2026 02:40 HKT/SGT
|
|
|
NTT DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion
Jan 30, 2026 22:50 JST
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
Jan 30, 2026 21:30 HKT/SGT
|
|
|
SuperX Commences Production at First Global Supply Center
Jan 30, 2026 19:24 HKT/SGT
|
|
|
Quam Plus Financial Proudly Serves as Gold Sponsor, The 3rd Hong Kong Capital Markets Forum 2026 Successfully Concludes
Jan 30, 2026 19:18 HKT/SGT
|
|
|
From Digitization to AI Computing: Cheche Group Inc. (CCG) Partners with Volkswagen DSSO and Cardif Airstar Insurance to Usher in the "Premium Era" of Advanced Smart Driving Insurance
Jan 30, 2026 18:35 HKT/SGT
|
|
|
Nissin Foods (Hong Kong) Charity Fund Supports Elite Athletes from The Education University of Hong Kong for the Fourth Consecutive Year
Jan 30, 2026 18:11 HKT/SGT
|
|
|
Shoucheng Holdings' Robotics Portfolio Gains Visibility as AI and Automation Take the Stage at China's 2026 CMG New Year's Gala
Jan 30, 2026 13:53 HKT/SGT
|
|
|
ANIME TOKYO STATION ON ROBLOX: Commemorating the One-Year Anniversary with Gifts and a Wealth of Add-on Content
Jan 30, 2026 9:00 JST
|
|
|
Formerra to Supply Foster Medical Compounds in Europe
Jan 29, 2026 22:00 HKT/SGT
|
|
|
Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline
Jan 29, 2026 20:57 HKT/SGT
|
|
|
LEGENDARY HUMANITY, Listed on Gate.io, Launches RWA Market for Contemporary Artist Mago Nagasaka
Jan 29, 2026 18:40 HKT/SGT
|
|
|
TCG.Zone Participates in a Historic Moment Surrounding the World's Only PSA 10 'Pikachu Illustrator'
Jan 29, 2026 18:30 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
